Trellus Management Company, LLC Soleno Therapeutics Inc Transaction History

Trellus Management Company, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$0.97 - $1.32 $12,233 - $16,647	-12,612 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$1.24 - $3.3 $806,000 - $2.15 Million	-650,000 Reduced 98.1%	12,612 $16,000
Q4 2020 Feb 10, 2021	BUY	$1.61 - $2.23 $396,349 - $548,981	246,180 Added 59.12%	662,612 $1.28 Million
Q3 2020 Oct 20, 2020	BUY	$1.71 - $2.51 $85,500 - $125,499	50,000 Added 13.65%	416,432 $1.05 Million
Q2 2020 Aug 12, 2020	SELL	$1.77 - $4.23 $141,246 - $337,554	-79,800 Reduced 17.88%	366,432 $813,000
Q4 2019 Feb 20, 2020	BUY	$1.35 - $2.95 $201,285 - $439,845	149,100 Added 50.18%	446,232 $1.31 Million
Q3 2019 Nov 01, 2019	BUY	$1.5 - $2.99 $43,698 - $87,104	29,132 Added 10.87%	297,132 $446,000
Q2 2019 Jul 31, 2019	BUY	$1.93 - $2.95 $52,795 - $80,697	27,355 Added 11.37%	268,000 $750,000
Q1 2019 Apr 23, 2019	BUY	$1.35 - $2.68 $96,207 - $190,990	71,265 Added 42.07%	240,645 $496,000
Q4 2018 Feb 04, 2019	BUY	$1.55 - $2.3 $25,654 - $38,067	16,551 Added 10.83%	169,380 $290,000
Q3 2018 Nov 05, 2018	BUY	$1.95 - $3.07 $45,992 - $72,409	23,586 Added 18.25%	152,829 $330,000
Q2 2018 Jul 25, 2018	BUY	$1.56 - $3.1 $201,619 - $400,653	129,243 New	129,243 $302,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $468M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.